Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Skin and Connective Tissue Diseases
|
Brands: Please see report, Please see report, Please see report, Please see report, Please see report, Please see report, Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: PIMECROLIMUS |
ATC code: D11A X15
|
Document link:
ASM981 0301-0301E1 Art45 listing 2011.xls
|
Document date: 2011-11-03
|
Study number: ASM981 0301/ 0301E1 |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|